Ocular Therapeutix

OCUL • NASDAQ • Stock Fundamentals

Ocular Therapeutix is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Pravin U. Dugel, with a market cap of $1.9B.

Market Cap$1.9B

Employees267.0

CEOPravin U. Dugel

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Ocular Therapeutix

Ocular Therapeutix (OCUL) has a market capitalization of $1.9B and trades on NASDAQ.

Ocular Therapeutix has approximately 267 employees.